- Home
- HKIT vs ADTX Comparison
HKIT vs ADTX Comparison
Compare HKIT & ADTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HKIT | ADTX |
|---|---|---|
| Founded | 1996 | 2017 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 725.9K | 641.6K |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | HKIT | ADTX |
|---|---|---|
| Price | $0.82 | $0.22 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 20.0M | 1.2M |
| Earning Date | 04-24-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 62.32 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,195.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.03 | $0.05 |
| 52 Week High | $4.21 | $7.13 |
Technical Indicators
Market Signals| Indicator | HKIT | ADTX |
|---|---|---|
| Relative Strength Index (RSI) | 45.87 | 31.49 |
| Support Level | $0.53 | $0.05 |
| Resistance Level | $2.08 | $1.11 |
| Average True Range (ATR) | 0.15 | 0.05 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 7.52 | 7.57 |
Price Performance
Historical ComparisonAbout HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.